Editorial: Efficacy, Toxicology, and PK/PD of Nanomedicine Administrated by Different Strategies

E-ISSN： 1875-5453|19|2|84-84

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.19, Iss.2, 2018-04, pp. : 84-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Translational PK-PD modeling in pain

By Yassen Ashraf

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 40, Iss. 3, 2013-06 ,pp. : 401-418

Springer Publishing Company

Access to resources Recommend Favorite

On translation of antibody drug conjugates efficacy from mouse experimental tumors to the clinic: a PK/PD approach

By Haddish-Berhane Nahor Shah Dhaval Ma Dangshe Leal Mauricio Gerber Hans-Peter Sapra Puja Barton Hugh Betts Alison

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 40, Iss. 5, 2013-10 ,pp. : 557-571

Springer Publishing Company

Access to resources Recommend Favorite

Streamlining the PK/PD data transfer process

By Collins Arthur

Pharmaceutical Programming, Vol. 3, Iss. 1, 2010-06 ,pp. : 24-28

Maney Publishing

Access to resources Recommend Favorite

Sample Size Computations for PK/PD Population Models

By Kang Dongwoo Schwartz Janice Verotta Davide

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 32, Iss. 5-6, 2005-12 ,pp. : 685-701

Springer Publishing Company

Access to resources Recommend Favorite

A Bayesian Approach for PK/PD Modeling with PD Data Below Limit of Quantification

By Zhou Huafeng

Journal of Biopharmaceutical Statistics, Vol. 22, Iss. 6, 2012-11 ,pp. : 1220-1243

Taylor & Francis Ltd

Access to resources Recommend Favorite